Comment on “5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity”
Main Authors: | Thomas Mørch Frøsig, Sine Reker Hadrup |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/871641 |
Similar Items
-
5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity
by: Thomas Stübig, et al.
Published: (2014-01-01) -
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
by: Richard L. Momparler
Published: (2012-08-01) -
5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
by: Nancy D. Ebelt, et al.
Published: (2020-03-01) -
5-Azacytidine: A Promoter of Epigenetic Changes in the Quest to Improve Plant Somatic Embryogenesis
by: Pedro Osorio-Montalvo, et al.
Published: (2018-10-01) -
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
by: Panagiotis Diamantopoulos, et al.
Published: (2019-05-01)